InvestSMART

Zelira Therapeutics Limited (ASX: ZLD) - Announcements

- Current share price for ZLD : $0.500

ASX company news and announcements for Zelira Therapeutics Limited (ZLD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Zelira Therapeutics Limited (ZLD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Zelira Therapeutics Limited (ZLD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Zelira Therapeutics Limited (ZLD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$7 Final Director's Interest Notice 1 Jun 2023 3:27PM $2.100 $0.500 fallen by 76.19%
$7 Proposed issue of securities - ZLD 31 May 2023 4:22PM $3.050 $0.500 fallen by 83.61%
$7 Zelira Non-Executive Director Appointed 31 May 2023 4:14PM $3.050 $0.500 fallen by 83.61%
$7 Top Line Results Investor Presentation 31 May 2023 11:46AM $2.900 $0.500 fallen by 82.76%
$7 Investor Webinar - Top line trial results 31 May 2023 10:41AM $1.200 $0.500 fallen by 58.33%
$7 Zeliras diabetic nerve pain drug outperforms Lyrica 31 May 2023 10:22AM $0.940 $0.500 fallen by 46.81%
$7 Trading Halt 29 May 2023 9:06AM $0.940 $0.500 fallen by 46.81%
$7 ZLD secures additional US$3.25M investment in HOPE SPV 22 May 2023 8:22AM $0.910 $0.500 fallen by 45.05%
$7 Appendix 4C Cash Flow Report 27 Apr 2023 12:03PM $0.935 $0.500 fallen by 46.52%
$7 March 2023 Quarterly Activities Report 27 Apr 2023 12:02PM $0.935 $0.500 fallen by 46.52%
$7 Section 708A Cleansing Notice 21 Mar 2023 7:27PM $0.970 $0.500 fallen by 48.45%
$7 Application for quotation of securities - ZLD 21 Mar 2023 7:25PM $0.970 $0.500 fallen by 48.45%
$7 Proposed issue of securities - ZLD 15 Mar 2023 9:30AM $1.000 $0.500 fallen by 50%
$7 Zelira raises A$1.77 million from US-based investors 15 Mar 2023 9:30AM $1.000 $0.500 fallen by 50%
$7 Trading Halt 13 Mar 2023 9:12AM $1.000 $0.500 fallen by 50%
$7 Appendix 4D & FY23 Interim Financial Report 28 Feb 2023 1:59PM $1.100 $0.500 fallen by 54.55%
$7 Zelira HOPE 1 SPV Investor Presentation 22 Feb 2023 1:08PM $1.050 $0.500 fallen by 52.38%
$7 Initial Director's Interest Notice 21 Feb 2023 8:12PM $1.005 $0.500 fallen by 50.25%
$7 Zelira HOPE 1 SPV Investor Briefing Webinar 21 Feb 2023 9:37AM $1.000 $0.500 fallen by 50%
$7 Zelira Executive Director Appointed 20 Feb 2023 12:37PM $1.180 $0.500 fallen by 57.63%
$7 Trading Halt 17 Feb 2023 9:32AM $1.180 $0.500 fallen by 57.63%
$7 ZLD secures US$8.6 million funding for HOPE 1 US FDA trials 15 Feb 2023 9:42AM $1.200 $0.500 fallen by 58.33%
$7 Trading Halt 13 Feb 2023 9:25AM $1.200 $0.500 fallen by 58.33%
$7 Appendix 4C Cash Flow Report 31 Jan 2023 8:36AM $0.990 $0.500 fallen by 49.49%
$7 December 2022 Quarterly Activities Report 31 Jan 2023 8:34AM $0.990 $0.500 fallen by 49.49%

101 - 125 of 546 results

Page 5 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.